Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 586 AL 600

Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson's disease associated with bowel dysfunction

Wang CP, Sung WH, Wang CC, Tsai PY.

Colorectal Dis. 2013 Mar;15(3):e130-7. doi: 10.1111/codi.12105.

Representation of action in Parkinson's disease: imagining, observing, and naming actions

Poliakoff E.

J Neuropsychol. 2013 Sep;7(2):241-54. doi: 10.1111/jnp.12005. Epub 2013 Jan 15.

Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Hare DJ, Adlard PA, Doble PA, Finkelstein DI.

Metallomics. 2013 Feb;5(2):91-109. doi: 10.1039/c2mt20164j.

Akinetic mutism and parkinsonism due to subdural and intraventricular tension pneumocephalus

Lütjens G, Capelle HH, Krauss JK.

J Neurol Surg A Cent Eur Neurosurg. 2013 Dec;74 Suppl 1:e116-8. doi: 10.1055/s-0032-1326941. Epub 2013 Jan 15.

The pharmacologic management of depression in Parkinson's disease

Schreiber MA, Thompson AW.

Degener Neurol Neuromuscul Dis. 2013 Jan 17;3:1-9. doi: 10.2147/DNND.S36917. eCollection 2013.

Glucocorticoid excess induces accumulation of cardiac glycogen and triglyceride: suggested role for AMPK

Puthanveetil P, Rodrigues B.

Curr Pharm Des. 2013;19(27):4818-30. doi: 10.2174/13816128113199990340.

The pathology roadmap in Parkinson disease

Surmeier DJ, Sulzer D.

Prion. 2013 Jan-Feb;7(1):85-91. doi: 10.4161/pri.23582. Epub 2013 Jan 1.

Impulse control disorders in Parkinson disease: is cognitive-behavioral therapy worth a wager?

Macphee GJ, Carson A.

Neurology. 2013 Feb 26;80(9):782-3. doi: 10.1212/WNL.0b013e31828407ef. Epub 2013 Jan 16.

Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers

Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS.

Neurology. 2013 Feb 26;80(9):792-9. doi: 10.1212/WNL.0b013e3182840678. Epub 2013 Jan 16.

The role of the subthalamic nucleus in cognition

Weintraub DB, Zaghloul KA.

Rev Neurosci. 2013;24(2):125-38. doi: 10.1515/revneuro-2012-0075.

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

Sanders LH, Timothy Greenamyre J.

Free Radic Biol Med. 2013 Sep;62:111-120. doi: 10.1016/j.freeradbiomed.2013.01.003. Epub 2013 Jan 15.

Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation

Heremans E, Nieuwboer A, Spildooren J, Vandenbossche J, Deroost N, Soetens E, Kerckhofs E, Vercruysse S.

J Neural Transm (Vienna). 2013 Apr;120(4):543-57. doi: 10.1007/s00702-012-0964-y. Epub 2013 Jan 18.

Palliative care and end-of-life planning in Parkinson's disease

Walker RW.

J Neural Transm (Vienna). 2013 Apr;120(4):635-8. doi: 10.1007/s00702-013-0967-3. Epub 2013 Jan 18.

Gender differences in Parkinson's disease: focus on plasma α-synuclein

Caranci G, Piscopo P, Rivabene R, Traficante A, Riozzi B, Castellano AE, Ruggieri S, Vanacore N, Confaloni A.

J Neural Transm (Vienna). 2013 Aug;120(8):1209-15. doi: 10.1007/s00702-013-0972-6. Epub 2013 Jan 18.

A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting

Chtarto A, Bockstael O, Tshibangu T, Dewitte O, Levivier M, Tenenbaum L.

Br J Clin Pharmacol. 2013 Aug;76(2):217-32. doi: 10.1111/bcp.12065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias